Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transasia Bio-Medicals is an Indian in vitro diagnostics and medical technology company focused on affordable diagnostic instruments, reagents, and testing solutions for laboratories and hospitals. Founded in 1979 by Suresh Vazirani, the company operates as part of the broader Erba group and serves India as well as many international markets. Its portfolio spans clinical chemistry, hematology, coagulation, ESR, immunology, urinalysis, diabetes management, microbiology, blood banking, critical care, and molecular diagnostics. Transasia also manufactures IVD products in India and has expanded through overseas acquisitions and a global distribution footprint. The business is best characterized as a commercial-stage diagnostics company rather than a therapeutics developer, with revenues driven by instrument sales, reagent consumables, and laboratory support services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Transasia Bio-Medicals.